Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Chamberlain

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Optometry and Vision Science : Official Publication of the American Academy of Optometry|July 26, 2019
A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia ControlPaul Chamberlain, Sofia C Peixoto-de-Matos, Nicola S Logan, et al.
Frontiers in Immunology|January 3, 2025
Comparative immunogenicity assessment of biosimilar natalizumab to its reference medicine: a matching immunogenicity profilePaul Chamberlain, Bernhard Hemmer, Josef Höfler, et al.
Expert Opinion on Biological Therapy|December 4, 2023
Pharmacokinetic and pharmacodynamic similarity of biosimilar natalizumab (PB006) to its reference medicine: a randomized controlled trialHendrik Wessels, Oliver von Richter, Maria Velinova, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|March 25, 2025
Eye growth and myopia progression following cessation of myopia control therapy with a dual-focus soft contact lensPaul Chamberlain, David S Hammond, Arthur Bradley, et al.
The AAPS Journal|January 8, 2026
Anti-drug Antibody Validation Testing and Reporting Harmonization AddendumHeather Myler, Johanna Mora, Joao Pedras-Vasconcelos, et al.
Rheumatology and Therapy|April 8, 2025
A Comparison of the Immunogenicity of Intravenous BAT1806, a Tocilizumab Biosimilar, and Its Reference ProductHans C Ebbers, Peter C Taylor, Xiaomei Leng, et al.
Head & Neck|June 28, 2018
Racial disparities in the choice of definitive treatment for squamous cell carcinoma of the oral cavityCarol M Lewis, Gaurav S Ajmani, Alexandra Kyrillos, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|April 25, 2023
Myopia Control Dose Delivered to Treated Eyes by a Dual-focus Myopia-control Contact LensViswanathan Ramasubramanian, Nicola S Logan, Susie Jones, et al.
Journal of Autism and Developmental Disorders|June 25, 2017
Psychophysiological and Behavioral Responses to a Novel Intruder Threat Task for Children on the Autism SpectrumMikle South, Katherine M Taylor, Tiffani Newton, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|January 27, 2022
Long-term Effect of Dual-focus Contact Lenses on Myopia Progression in Children: A 6-year Multicenter Clinical TrialPaul Chamberlain, Arthur Bradley, Baskar Arumugam, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Optometry and Vision Science : Official Publication of the American Academy of Optometry|July 26, 2019
A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia ControlPaul Chamberlain, Sofia C Peixoto-de-Matos, Nicola S Logan, et al.
Frontiers in Immunology|January 3, 2025
Comparative immunogenicity assessment of biosimilar natalizumab to its reference medicine: a matching immunogenicity profilePaul Chamberlain, Bernhard Hemmer, Josef Höfler, et al.
Expert Opinion on Biological Therapy|December 4, 2023
Pharmacokinetic and pharmacodynamic similarity of biosimilar natalizumab (PB006) to its reference medicine: a randomized controlled trialHendrik Wessels, Oliver von Richter, Maria Velinova, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|March 25, 2025
Eye growth and myopia progression following cessation of myopia control therapy with a dual-focus soft contact lensPaul Chamberlain, David S Hammond, Arthur Bradley, et al.
The AAPS Journal|January 8, 2026
Anti-drug Antibody Validation Testing and Reporting Harmonization AddendumHeather Myler, Johanna Mora, Joao Pedras-Vasconcelos, et al.
Rheumatology and Therapy|April 8, 2025
A Comparison of the Immunogenicity of Intravenous BAT1806, a Tocilizumab Biosimilar, and Its Reference ProductHans C Ebbers, Peter C Taylor, Xiaomei Leng, et al.
Head & Neck|June 28, 2018
Racial disparities in the choice of definitive treatment for squamous cell carcinoma of the oral cavityCarol M Lewis, Gaurav S Ajmani, Alexandra Kyrillos, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|April 25, 2023
Myopia Control Dose Delivered to Treated Eyes by a Dual-focus Myopia-control Contact LensViswanathan Ramasubramanian, Nicola S Logan, Susie Jones, et al.
Journal of Autism and Developmental Disorders|June 25, 2017
Psychophysiological and Behavioral Responses to a Novel Intruder Threat Task for Children on the Autism SpectrumMikle South, Katherine M Taylor, Tiffani Newton, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|January 27, 2022
Long-term Effect of Dual-focus Contact Lenses on Myopia Progression in Children: A 6-year Multicenter Clinical TrialPaul Chamberlain, Arthur Bradley, Baskar Arumugam, et al.
Pageof 5